#Japan #Tokyo #Regenesome #BeautyTech #Epigenetic Clock

Regenesome Selected as a Finalist in the Japan BeautyTech Awards 2025

Regenesome, a subsidiary of Space Seed Holdings, based in Minato, Tokyo, has announced its selection as a finalist in the 6th Japan BeautyTech Awards 2025 organized by Isthyle Inc. The evaluation focused on the theme of utilizing DNA methylation data for their innovative technology, the “Epigenetic Clock.” This award recognizes groundbreaking projects within the beauty and related sectors.

What is the Japan BeautyTech Awards?

The Japan BeautyTech Awards, hosted by Isthyle Inc., celebrate products, services, technologies, and initiatives across various industries such as beauty, fashion, and healthcare that hold the potential to make people happier through innovation. The judging panel, consisting of five experts, assesses the nominees based on five criteria: innovation, business viability, technical merit, social relevance, and intrinsic value. This year's awards saw a record 69 entries, from which 15 finalists were selected for further evaluation. The finalists then underwent presentations and Q&A sessions, leading to the selection of one grand prize and one runner-up, as well as two special awards.

Regenesome’s Aspirations

With the mission of providing anti-aging technology to expand human habitation on the Moon by 2040, Regenesome is a deep-tech startup committed to longevity science. The evaluated “Epigenetic Clock” technology is a cutting-edge analytical tool that accurately estimates biological age from DNA methylation data. By quantifying the progression of aging, Regenesome aims to offer personalized health and beauty solutions, paving the way for healthier lifestyles.

This technology is central to the company's “Healthspan Extension” project and is anticipated to be applied in researching aging phenomena in space environments as well.

Future Directions

Moving forward, Regenesome plans to continue its research and development, balancing the pursuit of scientifically-backed well-being with the establishment of health sciences in the era of space exploration. The recognition as a finalist in the Japan BeautyTech Awards will serve as a catalyst to further accelerate the implementation of biotechnology in the beauty and healthcare sectors.

About Regenesome

Regenesome seeks to provide new solutions for aging suppression and regenerative medicine by harnessing the potential of nanoparticles like exosomes. The company focuses on the detailed analysis of exosomes produced by various cells, while also designing nanoparticles at the molecular level to understand their functions within biological systems.

Through this research, Regenesome aims to develop medical technologies that employ nanoparticles and propose new solutions in the field of space medicine, contributing to the extension of health spans and humanity’s expansion into space.

For more information, visit Regenesome's Website.

About Space Seed Holdings

Space Seed Holdings operates as a deep-tech venture builder with a mission to turn sci-fi into reality through investment activities, research endeavors, and the creation of innovative businesses. They focus on societal issues, including the implementation of fermentation and longevity technologies, to generate solutions for pressing challenges.

Their goal is to equip humanity with the necessary technologies for sustainable living in outer space by the year 2040, collaborating with various stakeholders along the way.

For more information, visit Space Seed Holdings' Website.